PREGNANCY MULTIVITAMIN TABLET

Country: Kanada

Lingwa: Ingliż

Sors: Health Canada

Ingredjent attiv:

BETA-CAROTENE; VITAMIN B1 (THIAMINE MONONITRATE); VITAMIN B2 (RIBOFLAVIN); NICOTINAMIDE; D-PANTOTHENIC ACID (CALCIUM PANTOTHENATE); VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE); ASCORBIC ACID (ASCORBIC ACID); VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE); COPPER (COPPER GLUCONATE); IODINE (POTASSIUM IODIDE); IRON (FERROUS FUMARATE); MAGNESIUM (MAGNESIUM OXIDE); ZINC (ZINC OXIDE); FOLIC ACID; VITAMIN B12 (CYANOCOBALAMIN); VITAMIN D3 (CHOLECALCIFEROL); CALCIUM (CALCIUM CARBONATE)

Disponibbli minn:

JAMP PHARMA CORPORATION

Kodiċi ATC:

B03AE04

INN (Isem Internazzjonali):

IRON, MULTIVITAMINS AND MINERALS

Dożaġġ:

1.6MG; 3MG; 3.4MG; 20MG; 5MG; 10MG; 120MG; 13.8MG; 2MG; 0.15MG; 35MG; 50MG; 15MG; 1.1MG; 12MCG; 600UNIT; 300MG

Għamla farmaċewtika:

TABLET

Kompożizzjoni:

BETA-CAROTENE 1.6MG; VITAMIN B1 (THIAMINE MONONITRATE) 3MG; VITAMIN B2 (RIBOFLAVIN) 3.4MG; NICOTINAMIDE 20MG; D-PANTOTHENIC ACID (CALCIUM PANTOTHENATE) 5MG; VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 10MG; ASCORBIC ACID (ASCORBIC ACID) 120MG; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 13.8MG; COPPER (COPPER GLUCONATE) 2MG; IODINE (POTASSIUM IODIDE) 0.15MG; IRON (FERROUS FUMARATE) 35MG; MAGNESIUM (MAGNESIUM OXIDE) 50MG; ZINC (ZINC OXIDE) 15MG; FOLIC ACID 1.1MG; VITAMIN B12 (CYANOCOBALAMIN) 12MCG; VITAMIN D3 (CHOLECALCIFEROL) 600UNIT; CALCIUM (CALCIUM CARBONATE) 300MG

Rotta amministrattiva:

ORAL

Unitajiet fil-pakkett:

15G/50G

Tip ta 'preskrizzjoni:

Prescription

Sommarju tal-prodott:

Active ingredient group (AIG) number: 1747661005; AHFS:

L-istatus ta 'awtorizzazzjoni:

APPROVED

Data ta 'l-awtorizzazzjoni:

2023-02-22

Karatteristiċi tal-prodott

_ Pregnancy Multivitamin Product Monograph_
_ Page 1 of 30_
PRODUCT MONOGRAPH
PR
PREGNANCY MULTIVITAMIN
Vitamin-Mineral Supplement Tablets for Prenatal/Postpartum Use
Oral, Blue Tablet (evening) contains 1.1 mg of Folic Acid
Multivitamins and other Minerals Including Combinations
JAMP Pharma Corporation
1310 rue Nobel
Boucherville, Quebec
J4B 5H3, Canada
Control No.: 252149
Date of Revision:
February 22, 2023
_ Pregnancy Multivitamin Product Monograph_
_ Page 2 of 30_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
......................................................... 3
SUMMARY PRODUCT INFORMATION
...............................................................................................................
3
INDICATIONS AND CLINICAL USE
....................................................................................................................
4
CONTRAINDICATIONS
.........................................................................................................................................
4
WARNINGS AND PRECAUTIONS
........................................................................................................................
4
ADVERSE REACTIONS
..........................................................................................................................................
6
DRUG INTERACTIONS
........................................................................................................................................
10
DOSAGE AND ADMINISTRATION
....................................................................................................................
15
OVERDOSAGE
......................................................................................................................................................
16
ACTION AND CLINICAL PHARMACOLOGY
...................................................................................................
17
STORAGE AND STABILITY
...........................................................................